Applied dna submits pcr-based monkeypox virus diagnostic test for approval to new york state department of health

Stony brook, n.y.--(business wire)---- $apdn #ldt--applied dna sciences, inc. (nasdaq: apdn) ("applied dna" or the "company"), a leader in pcr-based dna technologies, announced today that its wholly-owned clinical laboratory subsidiary, applied dna clinical labs, llc ("adcl"), has submitted to the new york state department of health (nysdoh) a validation package for its company-developed monkeypox virus test in support of a request for full approval as a form of nysdoh laboratory developed test (ldt). the pcr
APDN Ratings Summary
APDN Quant Ranking